Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Jiedu Formula (扶正解毒) is a traditional Chinese medicine preparation that has been investigated in numerous clinical trials for a range of conditions. Its name translates to "supporting righteousness and resolving toxin," which reflects its principle of action in Traditional Chinese Medicine (TCM) to enhance the body's natural resistance while clearing pathogens or toxins. It has been studied as a treatment for viral infections like viral pneumonia and COVID-19, hematological disorders such as immune thrombocytopenia in children, and as an adjunctive therapy in oncology for colorectal and lung cancers to potentially improve outcomes and manage side effects like cancer-related fatigue. The formula is administered in various forms, including as granules and decoctions, and is often used alongside conventional Western medical treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Jiedu Formula.